These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7872723)

  • 41. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
    Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
    Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer.
    Moerkerk P; Arends JW; van Driel M; de Bruïne A; de Goeij A; ten Kate J
    Cancer Res; 1994 Jul; 54(13):3376-8. PubMed ID: 8012953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas.
    Shi CY; Phang TW; Wee A; Ngoi SS; Lin Y; Li B; Ong CN; Lee HP
    Ann Acad Med Singap; 1995 Mar; 24(2):204-10. PubMed ID: 7653961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
    Tornaletti S; Pfeifer GP
    Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 mutations in nonastrocytic human brain tumors.
    Ohgaki H; Eibl RH; Wiestler OD; Yasargil MG; Newcomb EW; Kleihues P
    Cancer Res; 1991 Nov; 51(22):6202-5. PubMed ID: 1933879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 point mutation and survival in colorectal cancer patients.
    Goh HS; Yao J; Smith DR
    Cancer Res; 1995 Nov; 55(22):5217-21. PubMed ID: 7585578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity in p53 mutations in mouse mammary tumor subpopulations with different metastatic potential from the orthotopic site.
    Shekhar PV; Werdell J; Christman JK; Miller FR
    Anticancer Res; 1995; 15(3):815-20. PubMed ID: 7645964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph node metastases.
    Zariwala M; Schmid S; Pfaltz M; Ohgaki H; Kleihues P; Schäfer R
    Verh Dtsch Ges Pathol; 1994; 78():252-4. PubMed ID: 7533994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid, efficient genotyping of clinical tumor samples by laser-capture microdissection/PCR/SSCP.
    Dillon D; Zheng K; Costa J
    Exp Mol Pathol; 2001 Jun; 70(3):195-200. PubMed ID: 11417998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep.
    Dequiedt F; Kettmann R; Burny A; Willems L
    Virology; 1995 Jun; 209(2):676-83. PubMed ID: 7778302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA polymerase beta mutations in human colorectal cancer.
    Wang L; Patel U; Ghosh L; Banerjee S
    Cancer Res; 1992 Sep; 52(17):4824-7. PubMed ID: 1511447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene.
    Mazars GR; Jeanteur P; Lynch HT; Lenoir G; Theillet C
    Oncogene; 1992 Apr; 7(4):781-2. PubMed ID: 1565474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 mutations detected in colorectal carcinoma patients in Hong Kong.
    Leung CS; Cheung MH; Wong CM; Lau KW; Tang CM; Lung ML
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):925-30. PubMed ID: 9367066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p53 mutations in basal cell carcinomas.
    Rady P; Scinicariello F; Wagner RF; Tyring SK
    Cancer Res; 1992 Jul; 52(13):3804-6. PubMed ID: 1617650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asymmetric PCR-based strategy for genetic analysis of the p53 tumor suppressor gene in cell lines and tumor tissues.
    Bártek J; Iggo R; Vojtĕsek B; Lane DP
    Neoplasma; 1991; 38(1):93-9. PubMed ID: 1707144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.
    Ohgaki H; Eibl RH; Schwab M; Reichel MB; Mariani L; Gehring M; Petersen I; Höll T; Wiestler OD; Kleihues P
    Mol Carcinog; 1993; 8(2):74-80. PubMed ID: 8397797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in the p53 tumor suppressor gene in colorectal cancer in Taiwan.
    Chang FH; Tzeng DS; Lee TM; Chen TC; Hsu LS; Lung FW
    Kaohsiung J Med Sci; 2003 Apr; 19(4):151-8. PubMed ID: 12795343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53 gene mutations in oral carcinomas from India.
    Munirajan AK; Tutsumi-Ishii Y; Mohanprasad BK; Hirano Y; Munakata N; Shanmugam G; Tsuchida N
    Int J Cancer; 1996 May; 66(3):297-300. PubMed ID: 8621246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.